Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from C-Rad AB Class B ( ($SE:CRAD.B) ).
C-RAD has secured a 10 MSEK contract to supply a Texas cancer center with its Surface Guided Radiation Therapy solutions, including Catalyst+ HD™ and Sentinel™ 4DCT. This order marks a strategic expansion for C-RAD in the US market, reinforcing its commitment to precision and safety in radiation therapy and strengthening its partnership with a leading healthcare institution.
More about C-Rad AB Class B
C-RAD is a company specializing in surface-guided imaging solutions for radiation therapy, aiming to deliver accurate dose delivery to tumors while protecting healthy tissue. Their technology utilizes high-speed 3D cameras and augmented reality to enhance patient setup and motion monitoring during treatment, ensuring safety and efficiency without additional imaging doses.
Average Trading Volume: 38,187
Current Market Cap: SEK1.17B
For detailed information about CRAD.B stock, go to TipRanks’ Stock Analysis page.